Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00143481
Status:
COMPLETED
Last Update Posted:
2021-01-27
First Post:
2005-09-01
Brief Title:
Effect of Detrol LA on Overactive Bladder Symptoms Sexual Quality of Life and Sexual Function in Women
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Study Overview
Official Title:
A Multi-Center Double-Phase Randomized Double-Blind Placebo Controlled 12-Week Double-Blind Followed by 12-Week Open-Label Study Evaluating the Effect of Tolterodine ER on Urgency Urinary Incontinence UUI Urgency Frequency Sexual Quality of Life and Sexual Function in Women With Overactive Bladder
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None